Rapid Covid-19 testing cost to be halved in low income countries: Unitaid
Geneva: Unitaid, a global health initiative that works with partners to bring about innovations to prevent, diagnose and treat major diseases in low- and middle-income...
Pharmaceutical
Aurinia snags FDA approval for lupus nephritis med Lupkynis, its first drug launch
Aurinia has nabbed its first FDA approval with an OK for Lupkynis (voclosporin) to treat lupus nephritis, or kidney inflammation caused by systemic lupus erythematosus. And now...
Delhi: Need Medical Advice? You Won’t Need To Queue Up
New Delhi: Though Delhi government runs 38 hospitals, over 200 dispensaries and polyclinics and 500 mohalla clinics, the Covid-19 outbreak demonstrated that the best of...
AstraZeneca vaccine production unscathed after fire breaks out at Serum Institute of India Complex
Five people have died after a fire broke out at Serum Institute of India’s home base in the western state of Pune, the company revealed...
Lilly’s neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial
Bamlanivimab (LY-CoV555) significantly reduced the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities, Eli Lilly and Company (NYSE: LLY) announced....
Rhizen receives USFDA orphan drug designation for cancer drug
New Delhi: Drug firm Alembic Pharmaceuticals today said the US health regulator has granted orphan drug designation to its associate company Rhizen Pharmaceuticals SA’s RP6530...
Open More Channels – Moderate vaccine off take by health workers offers reality checks for the road ahead
The slow pace of vaccination in many states and non-show by scheduled recipients reveal much scope for improvement. At current speed, it may be several...
‘Vaccine recipients may get time, place options’
New Delhi: Vaccine recipients in the second round of the anti-Covid immunisation — people above 50 and those who are younger but with co-morbidities —...
With many Regeneron and Lilly antibodies going unused, new candidates aim to ease dosing and defeat variants
Thanks to dosing logistics, COVID-19 antibodies from Eli Lilly and Regeneron have gotten off to a slow start in the U.S., and now they’re facing a new stumbling block...
Is your office Covid-secure? Free online tool can calculate risk of virus spreading in poorly-ventilated places
LONDON: Researchers have developed a new online tool that can calculate the risk of Covid-19 transmission in poorly-ventilated places, showing that when two people are...